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Abstract
Background: Excessive daytime sleepiness (EDS) is often associated with increased adiposity, particularly when assessed in
the context of samples of sleep-disordered patients; however, it is unclear if this relationship is sustained among non-
clinical, population-based cohorts. This study aimed to investigate the relationship between EDS and a number of body
composition markers among a population-based sample of men and women.
Methods: This study assessed 1066 women aged 21–94 yr (median = 51 yr, IQR 35–66), and 911 men aged 24–92 yr
(median = 60 yr, IQR 46–73) who participated in the Geelong Osteoporosis Study (GOS) between the years 2001 and 2008.
Total body fat mass was determined from whole body dual-energy X-ray absorptiometry scans, and anthropometric
parameters (weight, height, and waist circumference) were measured. Lifestyle and health information was collected via
self-report. Sleepiness was assessed using the Epworth Sleepiness Scale (ESS). Scores of $10 were considered indicative of
EDS.
Results: Women: After adjusting for age, alcohol intake, antidepressant medication use and physical activity, EDS was
associated with greater waist circumference and body mass index (BMI). EDS was also associated with 1.5–1.6-fold increased
odds of being overweight or obese. Men: After adjusting for age, alcohol use, physical activity and smoking status, EDS was
associated with greater BMI. These findings were not explained by the use of sedative or antidepressant medication. EDS
was also associated with 1.5-fold increased likelihood of being obese, independent of these factors. No differences in lean
mass, %body fat, or %lean mass were detected between those with and without EDS for men or women.
Conclusions: These data suggest that EDS is associated with several anthropometric adiposity profiles, independent of
associated lifestyle and health factors. Among women, symptoms of EDS are pervasive at both overweight and obese BMI
classifications; suggesting a need for further clinical examination to assess possible temporal associations with underlying
sleep pathology.
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Introduction
Prevalence of overweight and obesity are increasing significantly
throughout both the developed [1] and developing worlds [2].
Recent local studies report that between 3.5–7.6% of children and
approximately 20% of adults are classified as obese (kg/m2) [3–5].
This trend is consistently mirrored in most countries, across
socioeconomic standings [2] and gender [6]. The clinical and
societal implications of obesity have been well documented. Excess
weight and body fat, particularly that which is viscerally or
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centrally located, has been found to be a predisposing factor for an
increased risk for type 2 diabetes, poorer cardiovascular outcomes,
stroke, heart attacks, increased medical comorbidity, depression
and increased risk of sleep disorders [7,8].
Obesity has been proposed to affect sleep architecture via a
combination of impairment to physiological mechanisms, which
act to maintain upper airway patency, and functional alterations
between respiratory drive and load compensatory mechanisms [9].
Consequently, obese individuals are more likely to exhibit
decreased respiratory function, resulting in periods of hypoxemia,
hypercapnia and respiratory resistance [10,11]. Nocturnal respi-
ratory disturbances observed in obese individuals often manifest as
instances of compromised sleep architecture and excessive daytime
sleepiness (EDS) [12]. Indeed, obese individuals are more likely to
report symptoms of EDS than are non-obese individual [13], and
this association has also been found among non-apnoeic obese
populations [12]. Although the relationship between OSA and
obesity has been well documented, particularly among clinical
samples [14], several authors have described a lack of association
between these factors, particularly at a population level [14,15];
and have instead cited peripheral indicators such as metabolic
syndrome and lifestyle factors as having a closer association with
EDS [16].
The role of lifestyle and health factors as contributing factors in
the association between EDS and body composition is unclear.
Longitudinal research has shown that engagement in regular
exercise aids in the reduction of total body fat, %body fat, BMI
and weight and improves sleep quality especially slow wave sleep
[17,18], and dietary improvements contribute to a greater
reduction of body weight and abdominal fat [19]. Conversely,
poor diet, maladaptive lifestyle habits, and physical inactivity have
all been associated with greater index of adiposity and obesity [20],
as well as poorer sleep quality [21]. Despite these findings, there is
a paucity of studies incorporating these factors as possible
contributory factors when assessing EDS and body composition.
Indeed, many of these studies investigate aspects of lifestyle and
health in isolation, or among specific patient groups [19], and thus
it is unclear whether these factors represent possible modifiable
factors.
The mechanism by which EDS influences body composition
requires further elucidation; particularly in population-based
samples. Similarly, the role of a number of lifestyle and health
variables as contributory factors to this association is equivocal.
Daytime sleepiness is a common symptom among obese people,
and lifestyle and health factors have been shown to represent
possible modifiable factors in the expression of both conditions.
Therefore, there is a need to assess the relationship between EDS
and body composition in a representative, population-based
cohort, whilst controlling for a number of commonly associated
lifestyle and health factors.
Methods
Participants
This study examined men and women who participated in the
Geelong Osteoporosis Study (GOS). The GOS is a large,
population based, age-stratified cohort study conducted in south-
eastern Australia. Participants were selected at random from
Commonwealth electoral rolls for the Barwon Statistical Division.
Between the years 1993–1997, 1494 women were randomly
recruited, representing 77.1% participation [22]. At the 10-year
follow up (2004–2008), 881 women from the original sample
returned (82.1%) and were complemented by the inclusion of an
additional 246 randomly-selected women aged between 20–29
years. Of the 1126 women who participated in the 10-year follow
up, participants for whom weight and/or height (n = 38) and sleep
data (n = 22) were not available, were excluded, resulting in a total
of 1066 eligible women aged 20–94 years.
Between the years 2001–2006, 1540 men were recruited for
baseline analysis, representing a response of 67% [22]. Of the 979
men who participated in the 5-year follow up (81% response),
participants for whom follow-up (n= 1) weight and/or height
(n = 35) and sleep data (n = 32) were not available were excluded
from analysis, resulting in a total of 911 eligible men aged between
24–92 years.
Written informed consent was obtained from each participant.
Approval to conduct this study was granted under the project
numbers 92/01 and 00/56 from the Barwon Health Human
Research Ethics Committee.
Measurements
Epworth Sleepiness Scale. Instances of EDS were identified
using the Epworth Sleepiness Scale (ESS). Detailed descriptions of
the psychometric properties of the ESS have been detailed
elsewhere [23]. The ESS is considered to have good internal
validity and retest reliability, and is considered a low-cost and
effective measure of assessing sleepiness in adults [24]. The ESS
assesses an individual’s sleep propensity and likelihood of dozing
off in both soporific and engaging tasks via a self-administered 8-
item scale [24]. Sleepiness is assessed using a 4-point Likert scale,
referring to an individuals’ likelihood of dozing in that particular
situation (0 =would never doze, 1 = slight chance of dozing,
2 =moderate chance of dozing, 3 = high chance of dozing). Scores
range from 0–24, with higher scores reflecting higher levels of
sleepiness. At present, there are no universally adapted cut-off
ranges for the ESS; however similar studies have utilized a cut-off
score of $10 to indicate EDS [25].
Body composition. Anthropometric measurements were
recorded objectively. Height and weight were measured to the
nearest 60.1 cm and 60.1 kg, respectively. Body mass index
(BMI) was calculated as weight/height squared (kg/m2). A BMI of
,25 kg/m2 was considered normal weight, $25 kg/m2 to ,
30 kg/m2 was considered overweight, and $30 kg/m2 as obese.
Waist circumference was measured halfway between the margin of
the lower rib and iliac crest using a narrow metal anthropometric
tape measure. Participants were classified as obese if they reported
a waist measurement of$102 cm (men) or$88 cm (women) [26].
Fat mass was determined from whole body dual-energy X-ray
absorptiometry scans. Total percentage fat mass, lean mass and
bone mineral content (BMC) were calculated by dividing fat mass,
lean mass or BMC by the sum of fat mass, lean mass and BMC
(expressed as %). Automated upper arm digital blood pressure
monitors (UA-767) were used to measure systolic and diastolic
blood pressures (mmHg).
Lifestyle and heath factors. Information regarding alcohol
consumption and daily energy intake were obtained from the
Cancer Council food frequency questionnaire [27]. Daily alcohol
usage was expressed as gram intake per day (g/day), and energy
intake was assessed as kilojoule intake per day (kJ/day). Physical
activity levels were assessed via self-report and transformed into a
binary variable. Participants were classified as ‘active’ if they
reported ‘moving, walking and working energetically and partic-
ipating in vigorous exercise’. Alternatively, participants were
classified as sedentary. Self-reported tobacco smoking was
documented, and grouped as ‘current’ or ‘not’. Medication use
(sedatives and antidepressants) was determined using self-report
and usage was classified as ‘current’ if participants reported use at
the time of assessment. Socioeconomic Status was determined by
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use of the Socio-economic Index for Areas (SEIFA) index values
ascertained from the 2006 Australian Bureau of Statistics data.
SEIFA values were applied to obtain an aggregated Index of
Relative Socio-Economic Advantage and Disadvantage (IRSAD).
Participants were categorised into five groups, according to
quintiles of IRSAD for the study region. Quintile 1 represented
the most disadvantaged group, and quintile 5 represented the most
advantaged. Participants’ perceived general health status was
obtained via self-report and classified on a 5-point Likert scale,
expressed as (1) Excellent, (2) Very good), (3), Good, (4), Fair, and
(5) Poor. The presence of diabetes was identified by combination
of self-report and/or use of insulin or oral hypoglycemic agents.
Statistical analysis
Differences in characteristics between those with and without
EDS were analysed using t-tests for parametric continuous data,
Mann-Whitney test for non-parametric continuous variables and
Chi-Square test analysis for discrete variables. Fisher’s Exact Test
was used for non-parametric variables where expected cell sizes
were less than five. Differences in body composition (those
expressed as continuous variables) between those with and without
EDS were compared using linear regression techniques. Differ-
ences in body composition expressed as categorical variables (waist
circumference, BMI categories) were tested using logistic regres-
sion models. In all models, EDS (yes/no) was applied as the
exposure variable. Age, alcohol use, physical activity levels,
smoking status, energy intake, sedative and antidepressant use
were tested sequentially, and potential confounders and effect
modifiers were checked in statistical models. All statistical analyses
were completed using Minitab (Version 16; Minitab, State College
Pa).
Results
Women
Subject characteristics are presented in Table 1. Overall, 146
(13.7%) women were classified as having EDS. The median age
for this sample was 51 yr (range 20.9–93.6 yr), and women with
EDS tended to be slightly older than those who did not report
EDS. Median BMI for this cohort was 26.3 kg/m2. A large
percentage (60.0%) of this sample was considered overweight
(31.1%) or obese (28.9%) based on BMI criteria.
Those who reported EDS were more likely to be overweight or
obese. Women who report EDS were more likely have a greater
waist circumference, were more likely to be classified as centrally
obese (waist circumference $88 cm), and had greater fat mass
than those who were did not report EDS. No differences were
detected between women with and without EDS in terms of
%body fat, % BMC, %lean mass, energy intake, or blood pressure
(diastolic and/or systolic).
Relationships between EDS and lifestyle factors are also shown
in Table 1. Those with EDS were more likely report negative
health status, and higher instances of ‘poor’ self-perceived health.
Those with EDS were more likely to have diabetes than those who
were not sleepy. No differences were found in terms of
socioeconomic status, smoking status, medication use, physical
activity or alcohol intake between those with and without EDS.
After adjusting for age, alcohol intake, antidepressant medica-
tion use and physical activity, EDS was associated with greater
total waist circumference [Mean IQR: 93.6 (91.2–96.1) vs. 91.0
(89.5–92.6) cm, p= 0.03] and BMI [Mean IQR: 30.0 (29.0–31.1)
vs. 29.1 (28.4–29.7) kg/m2, p= 0.07]. Compared to women of
normal weight, having EDS was also associated with 1.5-fold
increased odds of being overweight (adjusted OR=1.5, 95%CI
1.0–2.3, p = 0.04), and 1.6-fold increased odds of being obese
(adjusted OR=1.6, 95%CI 1.1–2.3, p = 0.02) (Figure 1). These
findings were not explained by the use of sedative medication,
energy intake, or smoking status. A trend towards significance was
noted for overall weight [Mean IQR: 78.6 (48.2–109.0) vs. 76.0
(74.3–77.8) kg, p = 0.07], and for those with a waist circumference
$88 cm (adjusted OR=1.4, 95%CI 1.0–2.0, p = 0.08). No
differences in %body fat, %lean mass or fat mass were detected
between those with and without EDS when assessed using
multivariate modelling.
Men
Subject characteristics are presented in Table 1. Of the 911
men included in this study, 122 (13.4%), were classified as having
EDS. Men with EDS were more likely to be older and tended to
be shorter in height than those men who did not report EDS.
Overall, a considerable proportion of this sample of men met
criteria for overweight (50.3%) and obesity (22.4%). Those men
who reported EDS were more likely to have a larger overall waist
circumference, and were more likely to be classified as centrally
obese (waist circumference $102 cm). Those with EDS reported
lower daily energy intake and %BMC than those who did not
report EDS, and reported lower mean diastolic blood pressure. No
differences were found in terms of overall weight, overweight and/
or obesity based on BMI, %body fat, % lean mass, lean mass or fat
mass between groups.
Differences between lifestyle factors among those men with and
without EDS are presented in Table 1. Men with EDS were more
likely to report lower daily alcohol intake and report higher rates of
antidepressant medication use than those who were not sleepy. No
differences were found with regard to smoking status, sedative use,
diabetic status, health status, or socioeconomic status between
those with and without EDS.
After adjusting for age, alcohol use, physical activity and
smoking status, EDS was associated with greater BMI [Mean
IQR: 28.6 (27.5–29.7) vs. 27.2 (26.9–28.6) kg/m2, p= 0.03].
These findings were not explained by the use of sedative or
antidepressant medication use or energy intake. Compared to men
of normal weight, having EDS was also associated with a 1.5-fold
increased odds of being obese (adjusted OR=1.5, 95%CI 1.0–2.4,
p = 0.08) (Figure 2), independent of these factors. No differences in
total weight, total waist circumference, being overweight, %body
fat, % BMC or fat mass were found between those men with and
without EDS.
Discussion
This cross-sectional study identified a positive association
between EDS and several measures of adiposity among Australian
men and women. For women, after adjusting for medication and
lifestyle factors, EDS was associated with greater total weight,
waist circumference and BMI. Compared to women of normal
weight, having EDS was also associated with 1.5-fold increased
odds of being overweight and 1.6-fold increased odds of being
obese (on BMI criteria). A trend towards significance was also
noted for those women with EDS similarly having a waist
circumference greater than 88 cm. For men, following adjust-
ments, compared to men of normal weight, having EDS was
associated with 1.5-fold increased odds of being obese, as well as
greater BMI. These findings were not explained by the use of
sedative or antidepressant medication use or energy intake.
A novel finding of this study was the relationship between EDS
and several markers of adiposity, particularly among women,
following the application of waist circumference [28]. To our
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knowledge, this is the first study to demonstrate an association
between EDS and objectively measured viscerally located fat as
waist circumference has previously been shown to be an effective
measure of abdominal obesity, particularly when used in
conjunction with BMI [29]. Women who reported EDS were
more likely to have greater weight and BMI, and were more likely
to be overweight or obese than women who were not sleepy. This
finding is consistent with most, but not all of the existing literature
[30]. In a population-based study of 5508 women residing in
Sweden, participants who reported EDS were more likely to be
classified as obese, as indicated by, and less likely to be within the
ideal BMI range (defined as 20-,25 kg/m2) than women who
were not sleepy [28]. This finding is similar to comparable
research investigating EDS and BMI among population samples
[16]. Bixler and colleagues (2005) found a robust relationship
between EDS and BMI, demonstrating that the prevalence of
EDS increased exponentially in those classified as overweight
(average BMI= 28 kg/2). A similar finding was reported by both
Vgontzas et al (1998) and Resta et al (2003). Notably, our research
suggests that this association is comparably strong among both
overweight and obese women. Clinically, this finding is important
as it suggests the pervasiveness of these symptoms. Moreover, such
findings address the need for greater emphasis on gender-specific
treatment of EDS. Of the observed studies, a lack of specificity
regarding BMI classifications among female populations [28] or
the use of a combination of both male and female participants [16]
means that current recommendations regarding female patients
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Figure 1. Adjusted odds ratios for women with EDS for BMI
groups. Error bars represent the 95% CI. Group 1 (ideal BMI) is the
reference group, with a broken line indicating the threshold of
significance.
doi:10.1371/journal.pone.0112238.g001
Figure 2. Adjusted odds ratios for men with EDS for BMI
groups. Error bars represent the 95% CI. Group 1 (ideal BMI) is the
reference group, with a broken line indicating the threshold of
significance.
doi:10.1371/journal.pone.0112238.g002
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presenting with EDS is limited. Assessment of factors associated
with increased adiposity where female patients present with
symptoms of EDS may assist in streamlined treatment.
We demonstrated that men who reported EDS were more 1.5
times more likely to be classified as obese, and were more likely to
report a greater overall BMI than those who were not sleepy.
These findings are, in part, concordant with previous research,
which has demonstrated significant associations between EDS and
measure of obesity [16]. Compared to women, men with EDS
reported less overall energy intake, and reported less alcohol use
than those men who were not sleepy. Identification of adaptive
lifestyle and health behaviours, may therefore, present as
protective factors, however further examination is warranted in
order to assess the magnitude of these associations.
Waist circumference has previously been cited as a risk factor
for both obesity-related health risks such as sleep apnoea,
metabolic disturbance and all-cause mortality [31], however, this
finding is not universal [32]. We demonstrated that both men and
women who reported EDS were more likely to report greater waist
circumference. As waist measurements of $88 cm in women has
been associated with increased risk for cardiovascular disease,
diabetes and metabolic syndrome [33], further analysis is
warranted to assess the impact of both the antecedent and impact
of these factors within population samples, and the relationship to
sleep heath. These findings were similarly represented among men
when univariate models were applied; however this was not
replicated following the application of multivariate regression
modelling. Indeed, traditional measures of abdominal obesity have
been shown to correlate poorly with sleep disturbances [34].
Therefore, assessment of upper abdominal obesity and measure-
ments of neck circumference may be more effective in assessing the
degree of sleep disturbances in these populations [11], however,
this guideline is contentious [35]. More detailed study is required
to assess the relationship between EDS and the relative
distribution of visceral fat in men if more definitive conclusions
are to be drawn.
The association between EDS and markers of adiposity within
this sample may, in part, be mediated by increased inflammatory
processes. Obesity is considered to represent a state of low-grade
inflammation of white adipose tissue, as a result of chronic
activation of the immune response [36]. Such processes increase
the risk for subsequent development of diabetes mellitus via insulin
resistance and reduction in glucose tolerance [36]. The inflam-
matory cytokine, Interleukin 6 (IL-6), has previously been shown
to be a primary determinant for EDS [37], and serum IL-6 levels
are associated with visceral adiposity [38]. Increased inflammatory
responses have also been attributed to diseases often associated
with obesity, such as diabetes. We demonstrated that women with
EDS exhibited higher rates of diabetes than those who did not
report these symptoms, which is consistent with previous research
that demonstrated a link between sleepiness and the presence of
underlying metabolic syndrome [39], and in line with studies
suggesting that untreated EDS is an independent risk factor for the
later development of diabetes among women [40]. However, we
report that no differences were found between men in regard to
diabetic status. It is acknowledged that information regarding
diabetes within this sample was assessed via self-report. Moreover,
blood pressure assessments were not routinely obtained at the
same time each day, and therefore some diurnal variation may
remain unaccounted for in these results. Thus, further data
regarding the role of EDS in metabolic functioning may assist in
clarity of results.
Increased prevalence of EDS among obese individuals have also
been cited to result from underlying psychiatric illness [12].
Indeed, we have previously demonstrated that women with EDS
are more likely to meet criteria for current or lifetime history of a
depressive disorder [41]. As mental disorders were not examined
for this study, it is possible that symptoms of EDS may, in part, by
mediated by these underlying disorders. Research conducted by
Williams et al (2009) reported that women with a lifetime history
of psychiatric illness are more likely to meet criteria for adiposity
than controls, therefore alluding to an association between body
composition and mental health [42]. To our knowledge, however,
no such comparison has been made between EDS and psychiatric
disorders specifically, and thus, any interpretations at this time are
premature.
No association was noted between EDS and measures of body
composition as assessed by the whole body DXA scans for women
or men, with the exception that men with EDS had lower %BMC
than those who did not report EDS. As we did not have regional
DXA assessment of the central area, we are unable to make
inferences regarding central fat deposition. Further research is
therefore needed to assess the association between EDS and the
distribution of body fat.
Several methodological limitations must be identified when
interpreting the findings of the current study. Given that the study
was cross-sectional, no inferences can be made as to the
directionality of the observed relationships between EDS and
adiposity. Therefore, it is possible that the relationship may be
bidirectional. Moreover, interpretation of the results may not
generalizable to other populations or regions. Third, it is
acknowledged that not all conditions that may affect EDS were
assessed, including insomnia or obstructive sleep apnoea (OSA),
which have been shown to be associated with EDS, particularly in
clinical samples [24]. We did not explicitly assess the presence of
underlying sleep disorders such as OSA, and therefore cannot
exclude that this may have contributed to our findings. Despite
this, research has shown a poor correlation between OSA and
EDS in population-based cohorts [16] and we have included a
comprehensive number of body composition assessments, which
have been shown to correlate with disease severity. Nevertheless,
to our knowledge, this is the first research to investigate the
relationship between EDS and adiposity utilizing several anthro-
pometric assessment measures in a population-based sample of
men and women. Moreover, we assessed and accounted for a
number of lifestyle and health factors, which are recognised as
being implicated in EDS, therefore addressing limitations of past
research.
We demonstrated that EDS is associated with increased
measures of adiposity, particularly in women, independent of
age, lifestyle factors and medication use. Given that both EDS and
markers of adiposity constitute significant markers for disease, the
findings of the study highlight the need to incorporate anthropo-
metric measures in routine clinical assessment of patients.
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